Suppr超能文献

伴有继发性骨骼畸形的多巴反应性肌张力障碍(Segawa综合征)

[Dopa-responsive dystonia (Segawa syndrome) with secondary skeleton deformity].

作者信息

Budrewicz Sławomir P, Góral MaLgorzata, Koszewicz Magdalena, Tarantowicz Piotr, Podemski Ryszard

机构信息

Z Katedry i Kliniki Neurologii Akademii Medycznej we Wrocławiu.

出版信息

Wiad Lek. 2006;59(9-10):713-5.

Abstract

Dopa-responsive dystonia (DRD) is a rare, autosomal dominant (GTP-cyclohydroxylase gen mutation on chromosome 14q) or rarely recessive (tyrosine hydroxylase gene mutation on chromosome 11p) inherited disorder. Both enzymes take part in dopamine synthesis. Their deficiencies cause the dopamine level reduction. The first clinical symptoms occur in the childhood. The authors present the case of a 24-year-old woman in whom the lower limb dystonia occurred when she was five. Then the trunk and upper limbs dystonia appeared with skeleton deformities leading to deep disability. DRD was recognized when she was 19 and L-Dopa was administered. The clinical status improved, dystonic movements disappeared completely. The authors indicate that DRD must be taken into account in differential diagnosis of movement disorders in children, mostly in progressive cases. Good effect of L-Dopa treatment is one of the basic phenomena helpful in DRD recognition.

摘要

多巴反应性肌张力障碍(DRD)是一种罕见的常染色体显性遗传病(14号染色体q臂上的GTP环化水解酶基因突变),极少数情况下为隐性遗传病(11号染色体p臂上的酪氨酸羟化酶基因突变)。这两种酶都参与多巴胺的合成。它们的缺乏会导致多巴胺水平降低。最初的临床症状出现在儿童期。作者报告了一例24岁女性病例,该患者5岁时出现下肢肌张力障碍。随后出现躯干和上肢肌张力障碍,并伴有骨骼畸形,导致严重残疾。19岁时确诊为DRD并开始使用左旋多巴治疗。临床症状改善,肌张力障碍运动完全消失。作者指出,在儿童运动障碍的鉴别诊断中,尤其是进行性病例,必须考虑到DRD。左旋多巴治疗效果良好是有助于识别DRD的基本现象之一。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验